Six years after early vaccine trials, the legacy of COVID-19 shots reflects science, public debate, and how perceptions continue to evolve.
Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance ...
An early Moderna COVID‑19 trial has resurfaced six years on, amid ongoing debate over vaccine risks, guidance and public trust.
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional ...
A survey of the NEJM Catalyst Insights Council finds that patient hesitancy is the top challenge, especially in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results